OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Structure-based discovery of novel piperidine-biphenyl-DAPY derivatives as non-nucleoside reverse transcriptase inhibitors featuring improved potency, safety, and selectivity: From piperazine-biphenyl-DAPYs to piperidine-biphenyl-DAPYs
Wenjuan Huang, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116668-116668
Closed Access | Times Cited: 6

Synthesis and anti-liver fibrosis activity of imidazole and thiazole compounds containing amino acids
Y. Gloria Meng, Jie Ren, Jingxin Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116311-116311
Closed Access | Times Cited: 5

Recent developments of pyrimidine appended HIV-1 non-nucleoside reverse transcriptase inhibitors
S. Maheen Abdul Rahman, Gurpreet Singh, Md. Sakirul Islam Khan, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108273-108273
Closed Access

Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Zhipei Sang, Shuheng Huang, Wanying Tan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility
Limin Zhao, Christophe Pannecouque, Erik De Clercq, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4906-4917
Open Access | Times Cited: 8

Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Lu Sun, Peng Nie, Luan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115847-115847
Closed Access | Times Cited: 6

The latest developments in the design and discovery of non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV
Junyi Li, Bing Ye, Shenghua Gao, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-18
Closed Access | Times Cited: 1

Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors (2019-2023)
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1

Diarylpyrimidines and related analogs as antiviral agents
Shuang‐Xi Gu, Jiong Chen, Yuan‐Yuan Zhu, et al.
Elsevier eBooks (2023), pp. 513-542
Closed Access

Page 1

Scroll to top